Risk for cytomegalovirus disease in patients receiving polymerase chain reaction-based preemptive antiviral therapy after allogeneic stem cell transplantation depends on transplantation modality

被引：25

作者：

Hebart, H ^{[1
]}

Brugger, W

Grigoleit, U

Gscheidle, B

Loeffler, J

Schafer, H

Kanz, L

Einsele, H

Sinzger, C

机构：

[1] Univ Tubingen, Med Klin & Poliklin, Abt 2, D-7400 Tubingen, Germany

[2] Univ Tubingen, Inst Hyg, Abt Med Virol, Tubingen, Germany

来源：

BLOOD | 2001年 / 97卷 / 07期

关键词：

D O I：

10.1182/blood.V97.7.2183

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：2183 / 2185

页数：3

共 9 条

[1]

BOECKH M, 1996, BLOOD S1, V88, pA643

[2]

EINSELE H, 1995, BLOOD, V86, P2815

[3] Risk factors for treatment failures in patients receiving PCR-based preemptive therapy for CMV infection [J].

Einsele, H ;

Hebart, H ;

Kauffman-Schneider, C ;

Sinzger, C ;

Jahn, G ;

Bader, P ;

Klingebiel, T ;

Dietz, K ;

Löffler, J ;

Bokemeyer, C ;

Müller, CA ;

Kanz, L .

BONE MARROW TRANSPLANTATION, 2000, 25 (07) :757-763

[4] Cytomegalovirus monitoring by polymerase chain reaction of whole blood samples from patients undergoing autologous bone marrow or peripheral blood progenitor cell transplantation [J].

Hebart, H ;

Schroder, A ;

Loffler, J ;

Klingebiel, T ;

Martin, H ;

Wassmann, B ;

Gerneth, F ;

Rabenau, H ;

Jahn, G ;

Kanz, L ;

Muller, CA ;

Einsele, H .

JOURNAL OF INFECTIOUS DISEASES, 1997, 175 (06) :1490-1493

[5] Increased incidence of cytomegalovirus disease after autologous CD34-selected peripheral blood stem cell transplantation [J].

Holmberg, LA ;

Boeckh, M ;

Hooper, H ;

Leisenring, W ;

Rowley, S ;

Heimfeld, S ;

Press, O ;

Maloney, DG ;

McSweeney, P ;

Corey, L ;

Maziarz, RT ;

Appelbaum, FR ;

Bensinger, W .

BLOOD, 1999, 94 (12) :4029-4035

[6] Screening for CMV-specific T cell proliferation to identify patients at risk of developing late onset CMV disease [J].

Krause, H ;

Hebart, H ;

Jahn, G ;

Muller, CA ;

Einsele, H .

BONE MARROW TRANSPLANTATION, 1997, 19 (11) :1111-1116

[7] RECOVERY OF HLA-RESTRICTED CYTOMEGALOVIRUS (CMV)-SPECIFIC T-CELL RESPONSES AFTER ALLOGENEIC BONE-MARROW TRANSPLANT - CORRELATION WITH CMV DISEASE AND EFFECT OF GANCICLOVIR PROPHYLAXIS [J].

LI, CR ;

GREENBERG, PD ;

GILBERT, MJ ;

GOODRICH, JM ;

RIDDELL, SR .

BLOOD, 1994, 83 (07) :1971-1979

[8] Late cytomegalovirus pneumonia in adult allogeneic blood and marrow transplant recipients [J].

Nguyen, Q ;

Champlin, R ;

Giralt, S ;

Rolston, H ;

Raad, I ;

Jacobson, K ;

Ippoliti, C ;

Hecht, D ;

Tarrand, J ;

Luna, M ;

Whimbey, E .

CLINICAL INFECTIOUS DISEASES, 1999, 28 (03) :618-623

[9] Comparison of immune reconstitution after unrelated and related T-cell-depleted bone marrow transplantation: Effect of patient age and donor leukocyte infusions [J].

Small, TN ;

Papadopoulos, EB ;

Boulad, F ;

Black, P ;

Castro-Malaspina, H ;

Childs, BH ;

Collins, N ;

Gillio, A ;

George, D ;

Jakubowski, A ;

Heller, G ;

Fazzari, M ;

Kernan, N ;

MacKinnon, S ;

Szabolcs, P ;

Young, JW ;

O'Reilly, RJ .

BLOOD, 1999, 93 (02) :467-480

← 1 →